For research use only. Not for therapeutic Use.
Bacitracin(Cat No.:A000534)is a polypeptide antibiotic primarily used to treat bacterial infections in skin wounds and minor cuts. It works by inhibiting cell wall synthesis in Gram-positive bacteria, effectively stopping bacterial growth. Commonly formulated in topical ointments, bacitracin is known for its efficacy against Staphylococcus aureus and Streptococcus species, making it a reliable choice for localized infections. Its minimal absorption through the skin limits systemic side effects, enhancing safety for topical use. Bacitracin remains a staple in infection prevention and wound care in clinical and home settings.
Catalog Number | A000534 |
CAS Number | 1405-87-4 |
Synonyms | NA |
Molecular Formula | C65H101N17O16S |
Purity | ≥95% |
Storage | 3 years -20C powder |
IUPAC Name | (4S)-4-[[(2S)-2-[[(4R)-2-[(1R,2R)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2R,3S)-1-[[(3R,6R,9R,12R,15R,18R,21R)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2R)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid |
InChI | InChI=1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36+,37-,40-,41-,42+,43+,44-,45-,46-,47-,48+,52-,53-,54-/m1/s1 |
InChIKey | CLKOFPXJLQSYAH-YBVXDRQKSA-N |
SMILES | CC[C@@H](C)[C@@H]1C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)NCCCC[C@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]2CSC(=N2)[C@@H]([C@H](C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4 |
Reference | <p>Stone, K. John, and Jack L. Strominger. /Mechanism of Action of Bacitracin: Complexation with Metal Ion and C55-Isoprenyl Pyrophosphate./ <em>PNAS</em> 68.12 (1971): 3223-227. Biological Laboratories, Harvard University. Web. 21 Aug. 2012.</p><p>Bell, Robert G. /Preparative High-Performance Liquid Chromatographic Separation and Isolation of Bacitracin Components and Their Relationship to Microbiological Activity./ <em>Journal of Chromatography</em> 590 (1992): 163-68. Web. 21 Aug. 2012.</p></span></p> |